United Therapeutics | Des Atouts



Assets Changement Date
Amarin USD 750.62M 49.24M 2024-09
Ardelyx USD 435.75M 67.89M 2024-12
Baxter International USD 25.78B 894M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Biogen USD 28.05B 263.9M 2024-12
BioMarin Pharmaceutical USD 6.99B 137.74M 2024-12
Gilead Sciences USD 56.43B 2.56B 2025-03
GlaxoSmithKline GBP 59.46B 1.41B 2024-12
Halozyme Therapeutics USD 2.06B 54.55M 2024-12
Insmed USD 2.03B 27.74M 2024-12
Ionis Pharmaceuticals USD 3B 77.42M 2024-12
J&J USD 180.1B 1.82B 2024-12
Moderna USD 14.14B 1.66B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
PTC Therapeutics USD 1.71B 137.21M 2024-12
Regeneron Pharmaceuticals USD 37.76B 317.5M 2024-12
Sarepta Therapeutics USD 3.96B 363.24M 2024-12
Teva Pharmaceutical Industries USD 39.33B 2.43B 2024-12
United Therapeutics USD 7.36B 240.9M 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



United Therapeutics Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.